BackBlack Bird Biotech Overview
Black Bird Biotech, Inc.

Black Bird Biotech Return on Equity

Black Bird Biotech (BBBT) has a ROE of 110.58%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

110.58%

Return on Equity

110.58%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Black Bird Biotech (BBBT) FAQ

Black Bird Biotech posts a ROE of 110.58%. That is above the sector sector average of 11.3%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near 11.3% is typical. Black Bird Biotech's 110.58% is higher that level. That is roughly 878.9% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Black Bird Biotech's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 110.58%; use YoY and peer views to separate noise from signal.

Context for BBBT's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.3%), and (3) consistency with growth and profitability. This page covers the first two; Black Bird Biotech's other metric pages and overview cover the third.

Questions & Answers